CD79A and infection: These results suggest that 7DW8-5 enhanced vaccine efficacy by limiting infection at the mucosal compartments in the immunized mice after the virus challenge, consistent with the virus-specific IgA and IgG antibody titer, weight loss, and survival data (Figure 1 and Figure 2).